![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/28 | |
A61P 3/10 |
(11) | Number of the document | 1802329 |
(13) | Kind of document | T |
(96) | European patent application number | 05792052.2 |
Date of filing the European patent application | 2005-10-05 | |
(97) | Date of publication of the European application | 2007-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2005/055017 |
Date | 2005-10-05 |
(87) | Number | WO 2006/037789 |
Date | 2006-04-13 |
(30) | Number | Date | Country code |
200401519 | 2004-10-05 | DK |
(72) |
BERGLUND, Petter, SE
HAMMELEV, Charlotte, DK
ESKILDSEN, Lone, DK
MADSEN, Johanne, DK
OLSEN, Helle, Aalund, DK
KIMER, Lone, L gstrup, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |
A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN |